These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 18911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.
    Doenhoff M, Bickle Q, Bain J, Webbe G, Nelson G.
    J Helminthol; 1980 Mar; 54(1):7-16. PubMed ID: 7373025
    [Abstract] [Full Text] [Related]

  • 6. Experimental chemoprophylaxis against schistosomiasis. II. Stage I comparison of lucanthone, hycanthone, niridazole and oxamniquine (UK 4271).
    Jewsbury JM.
    Ann Trop Med Parasitol; 1973 Dec; 67(4):431-8. PubMed ID: 4787715
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N.
    Rev Inst Med Trop Sao Paulo; 1980 Dec; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activity of known antischistosomal agents on early-developing forms of Schistosoma mansoni.
    Pereira LH, Pellegrino J, Mello RT.
    J Parasitol; 1975 Apr; 61(2):249-52. PubMed ID: 805229
    [Abstract] [Full Text] [Related]

  • 12. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC, de Jesus Pedro R, Deberaldini ER.
    Trans R Soc Trop Med Hyg; 1982 Apr; 76(5):652-9. PubMed ID: 7179419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The chemotherapy of schistosomiasis.
    Archer S.
    Annu Rev Pharmacol Toxicol; 1985 Apr; 25():485-508. PubMed ID: 3890709
    [No Abstract] [Full Text] [Related]

  • 15. Susceptibility of Schistosoma mansoni from Liberia and Puerto Rico to antischistosomal drugs.
    Bruckner DA.
    Am J Trop Med Hyg; 1974 Jul; 23(4):634-8. PubMed ID: 4367836
    [No Abstract] [Full Text] [Related]

  • 16. [Medical treatment of urogenital bilharziasis].
    El-Kabbaj M, Hassar M.
    Maghrib Tibbi; 1979 Dec; 1(3):263-7. PubMed ID: 550031
    [No Abstract] [Full Text] [Related]

  • 17. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine.
    Rees PH, Bowry HN, Roberts JM, Thuku JJ.
    Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.